Skip to content

Bioenergetic Technology

Using Bioenergetic Technology to heal our bodies and minds

Menu

  • Home
  • About us
  • Contact us

OvaScience Co-Founders’ Review of Female Infertility Published in Cell Metabolism

Uncategorized a-life-sciences, aging-and, article-regarding, discovery, focused-on-the, for-infertility, in-depth-review, life-sciences, publication, the-discovery, the-publication

OvaScienceSM, , a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today the publication of an in-depth review article regarding female infertility due to aging and poor egg quality.

Excerpt from:
OvaScience Co-Founders’ Review of Female Infertility Published in Cell Metabolism

Related posts:

  1. Faster, Easier, Better Results
  2. Seahorse Bioscience Announces AACR Travel Award Recipients
  3. Cornerstone Pharmaceuticals Announces Initiation of Phase II Clinical Trial of CPI-613 for the Treatment of Small Cell …
  4. Biorefinery Products: Global Markets
  • ← Seahorse Bioscience Announces AACR Travel Award Recipients
  • Seahorse Bioscience and the Cancer Research UK Beatson Institute Team Up Against Cancer →

Recent Posts

  • Reata gets FDA orphan drug status for bardoxolone methyl to treat PAH
  • New Subtle Energy Pattern Research Shows Increases in Cell Growth and Viability
  • Cornerstone Pharmaceuticals' CPI-613 Selected as One of Informa and Kantar Health 2014 Top 10 Most Interesting …
  • Cornerstone Pharmaceuticals Announces Positive Phase I Data for CPI-613 in Relapsed or Refractory AML Patients to be …
  • Cornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Hodgkin's or T-Cell Non …
Copyright © 2025 Bioenergetic Technology. All rights reserved.
Theme: Accelerate by ThemeGrill. Powered by WordPress.